AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
-7.28%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.09B
AUM Growth
+$2.09B
Cap. Flow
+$264M
Cap. Flow %
12.61%
Top 10 Hldgs %
53.53%
Holding
115
New
19
Increased
31
Reduced
8
Closed
12

Top Buys

1
QURE icon
uniQure
QURE
$54.6M
2
BDTX icon
Black Diamond Therapeutics
BDTX
$42.3M
3
SDGR icon
Schrodinger
SDGR
$38.7M
4
XLRN
Acceleron Pharma Inc.
XLRN
$27M
5
PYPL icon
PayPal
PYPL
$23M

Top Sells

1
MRNA icon
Moderna
MRNA
$48.1M
2
BNTX icon
BioNTech
BNTX
$23.4M
3
XNCR icon
Xencor
XNCR
$18.9M
4
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$11M
5
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$10.2M

Sector Composition

1 Healthcare 78.33%
2 Consumer Discretionary 16.23%
3 Financials 2.02%
4 Technology 1.61%
5 Communication Services 1.55%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AKBA icon
76
Akebia Therapeutics
AKBA
$827M
$3.22M 0.14%
425,000
– –
PRTA icon
77
Prothena Corp
PRTA
$452M
$3.21M 0.14%
300,000
– –
TCRR
78
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$3.1M 0.13%
400,000
– –
KLDO
79
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$3.08M 0.13%
500,500
– –
ORTX
80
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$3.01M 0.13%
400,000
+50,000
+14% +$377K
SYRS
81
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3M 0.13%
+506,138
New +$3M
AUTL
82
Autolus Therapeutics
AUTL
$383M
$3M 0.13%
500,000
– –
KDNY
83
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.74M 0.12%
1,000,000
– –
PRVL
84
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$2.44M 0.1%
+200,000
New +$2.44M
AXLA
85
DELISTED
Axcella Health Inc. Common Stock
AXLA
$2.05M 0.09%
600,000
+150,000
+33% +$513K
SYRE icon
86
Spyre Therapeutics
SYRE
$1.02B
$1.86M 0.08%
400,000
+100,000
+33% +$466K
PTLA
87
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.43M 0.06%
+200,000
New +$1.43M
IRWD icon
88
Ironwood Pharmaceuticals
IRWD
$201M
$1.12M 0.05%
110,532
– –
CRIS icon
89
Curis
CRIS
$21.5M
$1.06M 0.04%
1,500,000
– –
RIGL icon
90
Rigel Pharmaceuticals
RIGL
$710M
$546K 0.02%
+350,000
New +$546K
LPTX icon
91
Leap Therapeutics
LPTX
$12M
$395K 0.02%
+250,000
New +$395K
STML
92
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-360,000
Closed -$3.83M
DRNA
93
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-500,000
Closed -$11M
RETA
94
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-50,000
Closed -$10.2M
KRTX
95
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-50,000
Closed -$3.77M
LGF.A
96
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
– –
0
– –
XNCR icon
97
Xencor
XNCR
$594M
– –
-550,000
Closed -$18.9M
XLI icon
98
Industrial Select Sector SPDR Fund
XLI
$23B
– –
0
– –
XBI icon
99
SPDR S&P Biotech ETF
XBI
$5.29B
– –
0
– –
VKTX icon
100
Viking Therapeutics
VKTX
$3.02B
– –
-350,000
Closed -$2.81M
1 2 3
4
5